The study showed that 94% of all patients who correctly used the mask showed significant stabilisation and sometimes even improvement of the central diabetic maculopathy and vision with some patients seeing a reverse of their condition.
A Consultant Ophthalmic Surgeon at Ashford and St Peter’s NHS Hospital near London has found that treating the eyes of diabetic patients with the Noctura 400 eye mask might stabilise or even improve central diabetic retinopathy changes.
As a 20+ year type I diabetic, PolyPhotonix has removed my deepest fear of developing retinopathy complications. I’ve been using Noctura 400 for preventative purposes and haven’t slept so relaxed nights ever since!
Global leaders in research, including a company working on a cure for common causes of blindness, are to benefit from major investment in North-East innovators.
This event will explore how to effectively scale innovation, using public commissioning and procurement processes such as SBRI to tackle the important social challenges of our time.
The County Durham company is currently in the final phases of trials of the Noctura 400 Sleep Mask, but has gathered enough evidence for it to be fully CE Marked, while being able to impressive claims about the mask’s results.